Loading...
XETR
MRK
Market cap60bUSD
Dec 04, Last price  
119.40EUR
1D
-0.42%
1Q
8.99%
Jan 2017
20.42%
Name

Merck KGaA

Chart & Performance

D1W1MN
XETR:MRK chart
P/E
18.70
P/S
2.45
EPS
6.39
Div Yield, %
1.84%
Shrs. gr., 5y
—
Rev. gr., 5y
5.55%
Revenues
21.16b
+0.78%
5,870,300,0006,258,600,0007,057,100,0007,558,000,0007,747,000,0009,290,600,00010,276,400,00011,172,900,00011,095,100,00011,500,800,00012,844,700,00015,024,000,00015,327,000,00014,836,000,00016,152,000,00017,534,000,00019,687,000,00022,232,000,00020,993,000,00021,156,000,000
Net income
2.78b
-1.66%
658,900,000983,100,0003,500,100,000367,100,000366,300,000632,100,000606,500,000566,700,0001,202,200,0001,157,300,0001,115,000,0001,629,000,0002,605,000,0003,374,000,0001,320,000,0001,987,000,0003,055,000,0003,326,000,0002,824,000,0002,777,000,000
CFO
4.59b
+21.19%
732,500,000811,700,0001,218,300,0001,024,000,0001,371,300,0001,782,600,0001,271,200,0002,472,200,0002,225,500,0002,705,500,0002,195,200,0002,518,000,0002,696,000,0002,219,000,0002,856,000,0003,477,000,0004,616,000,0004,259,000,0003,784,000,0004,586,000,000
Dividend
Apr 28, 20250 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
URL
https://www.emdgroup.com/
IPO date
Oct 20, 1995
Employees
59,308
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT